Related Experiment Videos
[Immunological changes in Schönlein-Henoch patients].
Vutreshni Bolesti
|January 1, 1984
Summary
This study found significantly higher circulating immune complexes and elevated IgA and IgG levels in patients with active Schönlein-Henoch purpura. High levels of immune complexes and complement consumption indicate a poorer prognosis.
Area of Science:
- Immunology
- Rheumatology
- Pediatric Nephrology
Background:
- Schönlein-Henoch purpura (SHP) is a systemic vasculitis characterized by immune complex deposition.
- Understanding the immunological markers in active SHP is crucial for prognosis.
Purpose of the Study:
- To investigate serum immunoglobulin (IgA, IgG, IgM), complement levels, and circulating immune complexes (CICs) in patients with active SHP.
- To correlate these immunological findings with disease activity and prognosis.
Main Methods:
- Serum samples from 17 active SHP patients and healthy controls were analyzed.
- Levels of IgA, IgG, IgM, complement titre, and CICs were measured.
Main Results:
- SHP patients showed a four-fold increase in CICs compared to controls.
- Elevated serum IgA and, to a lesser extent, IgG levels were observed.
- Complement titre was reduced in active SHP patients.
- Extremely high CIC values and complement consumption correlated with a more unfavorable prognosis.
Conclusions:
- Active SHP is associated with increased CICs and altered immunoglobulin levels.
- Complement consumption is a significant finding in active SHP.
- Elevated CICs and complement consumption are indicators of a poorer prognosis in SHP.